Refine by
Periodontal Articles & Analysis
19 news found
Summary Did you know that between 64% and 93% of dentists and dental hygienists experience work-related musculoskeletal pain?1 The solution to working pain-free might lie in better ergonomics education. Ergonomics is vital in dentistry, where professionals often work in static, awkward positions that can lead to musculoskeletal disorders and chronic pain. Proper ergonomic practices can help ...
XPhyto’s proprietary ODF biosensor development portfolio includes multiple oral health products, including for the detection of stomatitis, periodontitis, and periimplantitis. The Company’s first ODF biosensor screening product is for general oral inflammation. ...
XPhyto’s proprietary ODF biosensor development portfolio includes multiple oral health products, including for the detection of stomatitis, periodontitis, and periimplantitis. The Company’s first ODF biosensor screening product is for general oral inflammation. ...
Giuseppe Intini, DDS, PhD, Associate Professor of Periodontics and Preventive Dentistry at the University of Pittsburgh, and faculty member at the McGowan Institute for Regenerative Medicine, will serve as the principal investigator for this study. ...
A dentist might recommend oral surgery for any of the following high-level reasons: Gum Disease Gum disease that has progressed significantly might need to be treated via periodontal surgery. This is commonly referred to as “gum ...
VAX-PG: Vaxcyte expects to nominate a final vaccine candidate for VAX-PG, its novel therapeutic vaccine designed to treat periodontal disease, by the end of 2022. First Quarter 2022 Financial Results Cash Position: Cash, cash equivalents and investments were $352.3 million as of March 31, 2022, compared to $273.1 million as of December 31, 2021. ...
Vaxcyte’s pipeline also includes VAX-XP, a PCV with an expanded breadth of coverage of greater than 30 strains; VAX-A1, a prophylactic vaccine candidate designed to prevent Group A Strep infections; and VAX-PG, a therapeutic vaccine candidate designed to slow or stop the progression of periodontal disease. Vaxcyte is driven to eradicate or treat invasive bacterial ...
Vaxcyte’s pipeline also includes VAX-XP, a PCV with an expanded breadth of coverage of greater than 30 strains; VAX-A1, a prophylactic vaccine candidate designed to prevent Group A Strep infections; and VAX-PG, a therapeutic vaccine candidate designed to slow or stop the progression of periodontal disease. Vaxcyte is driven to eradicate or treat invasive bacterial ...
Vaxcyte’s pipeline also includes VAX-XP, a PCV with an expanded breadth of coverage of greater than 30 strains; VAX-A1, a prophylactic vaccine candidate designed to prevent Group A Strep infections; and VAX-PG, a therapeutic vaccine candidate designed to slow or stop the progression of periodontal disease. Vaxcyte is driven to eradicate or treat invasive bacterial ...
Vaxcyte’s pipeline also includes VAX-XP, a PCV with an expanded breadth of coverage of greater than 30 strains; VAX-A1, a prophylactic vaccine candidate designed to prevent Group A Strep infections; and VAX-PG, a therapeutic vaccine candidate designed to slow or stop the progression of periodontal disease. Vaxcyte is driven to eradicate or treat invasive bacterial ...
Vaxcyte’s pipeline also includes VAX-XP, a PCV with an expanded breadth of coverage of greater than 30 strains; VAX-A1, a prophylactic vaccine candidate designed to prevent Group A Strep infections; and VAX-PG, a therapeutic vaccine candidate designed to slow or stop the progression of periodontal disease. Vaxcyte is driven to eradicate or treat invasive bacterial ...
Vaxcyte’s pipeline also includes VAX-XP, a PCV with an expanded breadth of coverage of greater than 30 strains; VAX-A1, a prophylactic vaccine candidate designed to prevent Group A Strep infections; and VAX-PG, a therapeutic vaccine candidate designed to slow or stop the progression of periodontal disease. Vaxcyte is driven to eradicate or treat invasive bacterial ...
Vaxcyte’s pipeline also includes VAX-XP, a PCV with an expanded breadth of coverage of greater than 30 strains; VAX-A1, a prophylactic vaccine candidate designed to prevent Group A Strep infections; and VAX-PG, a therapeutic vaccine candidate designed to slow or stop the progression of periodontal disease. Vaxcyte is driven to eradicate or treat invasive bacterial ...
"Many dogs, especially toy dog breeds, are predisposed to periodontal disease," said Steve Eby, Business Development Director at RevBio. ...
Fiorellini, DMD, DMSc, Professor and Director, Postdoctoral Periodontics Program at the University of Pennsylvania School of Dental Medicine and principal investigator for this grant. ...
Vaxcyte’s pipeline also includes VAX-XP, a PCV with an expanded breadth of coverage of greater than 30 strains; VAX-A1, a prophylactic vaccine candidate designed to prevent Group A Strep infections; and VAX-PG, a therapeutic vaccine candidate designed to slow or stop the progression of periodontal disease. Vaxcyte is driven to eradicate or treat invasive bacterial ...
Michal is currently working with supervisor Professor Sašo Ivanovski on the development of 3D printed scaffolds for bone and periodontal regeneration. ...
Oral conditions such as caries (cavities), periodontal (gum) disease, dental infections and other oral conditions share common risk factors (unhealthy diet, alcohol and tobacco use) with four chronic diseases recognized by the United Nations as non-communicable diseases: cancer, cardiovascular, respiratory and diabetes. ...
The integration of the AMD LASERS Picasso™ line of soft tissue dental lasers enables every dental practitioner to provide state-of-the-art treatment for soft tissue surgery, periodontal and endodontic procedures, and laser teeth whitening. AMD LASERS is an ISO 13485 and CE registered company. ...